Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Eric Hink, MD
Healthcare Professional Director
American Society of Ophthalmic Plastic
and Reconstructive Surgery (ASOPRS)
University of Colorado School of Medicine
13001 East 17th Place
Aurora, Colorado, United States
Eric Hink is Associate Professor of ophthalmology and Director of American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS) fellowship in oculofacial plastic and orbital surgery at University of Colorado School of Medicine. His interests include eyelid cancer and reconstruction, orbital trauma and reconstruction, thyroid eye disease, lacrimal surgery, and aesthetic facial surgery. He has an experience in treating conditions like facial fractures, pediatric cancer, facial paralysis, oculofacial plastic and orbital surgery, eye and/or orbital surgery, eye cancers, pediatric ophthalmology and adult strabismus, eye disease, thyroid disease, and ophthalmic oncology etc.
Dr. Hink received his medical degree from University of Colorado Denver School of Medicine followed by internship from Presbyterian-St Luke’s Medical Center Program, residency in ophthalmology and fellowship in oculoplastic and reconstructive surgery from University of Colorado.
Since joining the faculty at the University of Colorado School of Medicine, Dr. Hink has given national and international lectures and courses, and presented his research at national and international meetings.
Representative Publications:
Teprotumumab for Thyroid-Associated Ophthalmopathy
Tear Trough Incision for External Dacryocystorhinostomy
Pediatric Facial Fractures From Dog Bites
myBinderRelated Content
-
Prem Subramanian, MD, PhDPrem S. Subramanian is the Professor of ...
-
Michele Beaconsfield, FRCOphthMichele Beaconsfield is a consultant oph...
-
Study of RVT-1401 for the Treatment of Patients With Moderate to Severe Active Graves’ OphthalmopathyThe purpose of the current study is to c...
-
Surgical Treatment of Diplopia in Graves’ Orbitopathy PatientsPurpose: To review the authors' current...
-
The Medical University of South Carolina Health Graves’ Eye Disease ClinicThe Medical University of South Carolina...
-
New Data from Teprotumumab Phase 3 OPTIC Study Shows Significantly Reduced Double Vision and Improved Quality of Lif...Horizon Therapeutics plc today announced...
-
Protect Your Eyes: A Baseball Player’s StoryThyroid eye disease, also known as Grave...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Facebook
Google